It was another busy week for the fall IPO market as 13 IPOs raised $4.6 billion led by restaurant payment processor Toast (TOST), which jumped 56% in its debut. Six SPACs also went public, and one IPO postponed: Canadian consumer products...read more
Cue Health, which develops and sells molecular home tests for COVID-19 and other diseases, raised $200 million by offering 12.5 million shares at $16, within the range of $15 to $17. The company's Cue Integrated Care Platform consists of hardware and software...read more
Summer may be over, but the IPO market is just heating up as 14 IPOs are slated to raise $5.3 billion in the week ahead. The diverse group includes software, consumer products, payment technology, and more. The largest deal of the week,...read more
Cue Health, which develops and sells molecular home tests for COVID-19 and other diseases, announced terms for its IPO on Wednesday. The San Diego, CA-based company plans to raise $200 million by offering 12.5 million shares at a price range of $15 to $17. At...read more
US IPO Weekly Recap: Toast gets buttered up in a 13 IPO week
It was another busy week for the fall IPO market as 13 IPOs raised $4.6 billion led by restaurant payment processor Toast (TOST), which jumped 56% in its debut. Six SPACs also went public, and one IPO postponed: Canadian consumer products...read more
COVID-19 test maker Cue Health prices IPO at $16 midpoint
Cue Health, which develops and sells molecular home tests for COVID-19 and other diseases, raised $200 million by offering 12.5 million shares at $16, within the range of $15 to $17. The company's Cue Integrated Care Platform consists of hardware and software...read more
US IPO Week Ahead: Software, consumer products, and payment tech lead a diverse 14 IPO week
Summer may be over, but the IPO market is just heating up as 14 IPOs are slated to raise $5.3 billion in the week ahead. The diverse group includes software, consumer products, payment technology, and more. The largest deal of the week,...read more
COVID-19 test maker Cue Health sets terms for $200 million IPO
Cue Health, which develops and sells molecular home tests for COVID-19 and other diseases, announced terms for its IPO on Wednesday. The San Diego, CA-based company plans to raise $200 million by offering 12.5 million shares at a price range of $15 to $17. At...read more